Filter Results:
(6,981)
Show Results For
- All HBS Web
(6,981)
- People (27)
- News (2,580)
- Research (3,460)
- Events (14)
- Multimedia (224)
- Faculty Publications (2,235)
Show Results For
- All HBS Web
(6,981)
- People (27)
- News (2,580)
- Research (3,460)
- Events (14)
- Multimedia (224)
- Faculty Publications (2,235)
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- 24 Jun 2021
- Blog Post
Celebrating the Past, Crafting the Future Part 2: The First HBS/HKS Class
The first MBA/MPP and MBA/MPA-ID joint degree programs are 10 years old! 89% of HBS | HKS joint degree alumni have told us that they worked in a role allowing usage of both degrees. Learn more about a few members from the Class of 2011... View Details
- August 2006 (Revised September 2007)
- Supplement
Istituto Clinico Humanitas (C): Pronto Soccorso
By: Richard M.J. Bohmer
Follows on from the cases Istituto Clinico Humanitas (A) and (B). Describes the design and running of the new Humanitas Emergency Department. Istituto Clinico Humanitas has developed a very efficient operating system for dealing with elective (largely surgical)... View Details
Keywords: Health Care and Treatment; Organizational Change and Adaptation; Service Operations; Service Delivery; Customer Focus and Relationships; Health Industry; Italy
Bohmer, Richard M.J. "Istituto Clinico Humanitas (C): Pronto Soccorso." Harvard Business School Supplement 607-022, August 2006. (Revised September 2007.)
- February 1992 (Revised September 2003)
- Case
Beech-Nut Nutrition Corporation (A-1)
By: Lynn S. Paine
The CEO of Beech-Nut Nutrition Corp. must decide what to do when he receives information that the company's supply of apple juice concentrate may be adulterated. The concentrate is used in many of the company's juice products. It appears that others in the company may... View Details
Keywords: Quality; Law; Ethics; Nutrition; Management Teams; Decisions; Business or Company Management; Communication; Governance Compliance; Information Management; Corporate Finance; Food and Beverage Industry; United States
Paine, Lynn S. "Beech-Nut Nutrition Corporation (A-1)." Harvard Business School Case 392-084, February 1992. (Revised September 2003.)
- 31 Jan 2014
- Working Paper Summaries
The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay
- 09 Nov 2022
- Blog Post
Building Community: Meet the HBS Latino Student Organization Leadership
three of us represent Mexico, Dominican Republic, and Bolivia; hail from Los Angeles, New York, and La Paz; and worked in tech, finance, and startups before business school. We all bring excitement, passion y sabor to LASO’s leadership.... View Details
Paul W. Marshall
MBA Class of 1960 Professor of Management, Paul W. Marshall, is affiliated with the Entrepreneurial Management Unit and teaches The Entrepreneurial Manager in the Turnaround Environment. This Elective Curriculum course focuses on the role of... View Details
- July 2018
- Case
Ce Soir-Là, Ils n'Arrivent Plus Un par Un, Mais par Vagues: Coping with the Surge of Trauma Patients at L'Hôpital Universitaire La Pitié Salpêtrière—Friday, November 13, 2015
By: Herman B. "Dutch" Leonard, Emilie Billaud and Arnold M. Howitt
On November 13, 2015, Dr. Marie Borel, Dr. Emmanuelle Dolla, Dr. Frédéric Le Saché, and Professor Mathieu Raux were the doctors in charge of the trauma center at L’Hôpital de la Pitié Salpêtrière in Paris, where dozens of wounded and dying patients, most with severe... View Details
Keywords: Health Care and Treatment; Crisis Management; Performance Capacity; Decision Making; Leadership; Health Industry; Europe; France; Paris
Leonard, Herman B. "Dutch", Emilie Billaud, and Arnold M. Howitt. "Ce Soir-Là, Ils n'Arrivent Plus Un par Un, Mais par Vagues: Coping with the Surge of Trauma Patients at L'Hôpital Universitaire La Pitié Salpêtrière—Friday, November 13, 2015." Harvard Business School Case 319-032, July 2018.
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- Program
The Women's Leadership Forum
living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis,... View Details
- Program
Senior Executive Leadership Program—India
carefully designed to facilitate your growth. Your learning will take place on your own, in your small learning group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Read... View Details
- Program
Investment Management Workshop
facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We... View Details
- March 2014 (Revised November 2020)
- Case
The Novartis Malaria Initiative
By: Michael Chu, Vincent Marie Dessain and Emilie Billaud
The Novartis Malaria Initiative was designed, as a result of a precedent–setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria—"at no profit"—for public health systems. What had begun as an exemplary act of... View Details
Keywords: Health Care and Treatment; Product Marketing; Corporate Social Responsibility and Impact; Social Enterprise; Pharmaceutical Industry; Switzerland; Africa; Nigeria
Chu, Michael, Vincent Marie Dessain, and Emilie Billaud. "The Novartis Malaria Initiative." Harvard Business School Case 314-103, March 2014. (Revised November 2020.)
- June 5, 2023
- Article
How to Tap the Full Potential of Telemedicine
By: Mitchell Tang, Louise Short, Ryan June, Matthew Dowling and Ateev Mehrotra
Telemedicine visits in the United States have fallen sharply since April 2020, but the end of the pandemic should not spell the end of telemedicine. It can play a valuable role in the delivery of health care. The key to tapping its potential is to bring many elements... View Details
Tang, Mitchell, Louise Short, Ryan June, Matthew Dowling, and Ateev Mehrotra. "How to Tap the Full Potential of Telemedicine." Harvard Business Review (website) (June 5, 2023).
- 02 May 2017
- First Look
First Look at New Research: May 2, 2017
April 14, 2017 Harvard Business Review Companies Like United Need to Cultivate Good Judgment, and Free Their Employees to Use It By: Deighton, John A. Abstract—United Airlines has pledged to improve its training programs and empower its... View Details
Keywords: Carmen Nobel
- 12 Jun 2012
- First Look
First Look: June 12
customer, there is no value. Instead of using pricing in a way that turns customers into adversaries, companies can use it to enlarge the pie. That means viewing customers as partners in value creation-a... View Details
Keywords: Sean Silverthorne
- 2021
- Working Paper
Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent
By: Rembrand Koning, Sampsa Samila and John-Paul Ferguson
Has the increase in female medical researchers led to more medical advances for women? In this paper, we investigate if the gender of inventors shapes their types of inventions. Using data on the universe of U.S. biomedical patents, we find that patents with women... View Details
Keywords: Innovation; Biomedical Research; Innovation and Invention; Diversity; Gender; Research; Health; United States
Koning, Rembrand, Sampsa Samila, and John-Paul Ferguson. "Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent." Working Paper. (Harvard Business School Working Paper, No. 19-124, June 2019; SSRN Working Paper Series, No. 3401889, June 2019.)
- 25 Feb 2019
- News
Impact investing: a new way to fund cures for cancer
- 13 Aug 2009
- Working Paper Summaries
In Favor of Clear Thinking: Incorporating Moral Rules into a Wise Cost-Benefit Analysis
Keywords: by Max H. Bazerman & Joshua D. Greene